Peter Brown

Stock price provided by Lang & Schwarz

Showing transactions by Peter Brown in Akebia Therapeutics, Inc..

Quarter	Type	Shares before	Shares after	Change	Price range
2025-Q1	Buy	3.8M	4M	+182K	€1.53–€2.33
2024-Q4	Buy	3.7M	3.8M	+106K	€1.17–€2.00
2024-Q3	Sell	3.9M	3.7M	-197K	€0.88–€1.44
2024-Q2	Buy	3.7M	3.9M	+263K	€0.78–€1.54
2024-Q1	Sell	4.8M	3.7M	-1.1M	€1.14–€2.09
2023-Q4	Buy	3.2M	4.8M	+1.6M	€0.76–€1.15
2023-Q3	Sell	3.3M	3.2M	-175K	€0.79–€1.59
2023-Q2	Buy	2.3M	3.3M	+992K	€0.47–€1.31
2023-Q1	Sell	2.9M	2.3M	-548K	€0.50–€1.07
2022-Q4	Sell	3M	2.9M	-130K	€0.22–€0.46
2022-Q3	Buy	1.5M	3M	+1.5M	€0.30–€0.45
2022-Q2	Buy	1M	1.5M	+479K	€0.30–€0.61
2022-Q1	Buy	623K	1M	+380K	€0.65–€2.52
2021-Q4	Sell	950K	623K	-327K	€2.00–€2.82
2021-Q3	Sell	1.8M	950K	-878K	€1.99–€3.20
2021-Q2	Buy	1.1M	1.8M	+757K	€2.32–€3.50
2021-Q1	Sell	1.4M	1.1M	-377K	€2.36–€4.04
2020-Q4	Buy	70K	1.4M	+1.4M	€1.88–€3.14
2020-Q3	Sell	76K	70K	-5.5K	€2.00–€12.10
2020-Q2	Sell	139K	76K	-63K	€6.15–€11.90
2019-Q4	Buy	43K	139K	+95K	€2.86–€5.85
2019-Q3	Sell	1.8M	43K	-1.7M	€3.15–€4.87
2018-Q3	Sell	2.5M	1.8M	-742K	€6.35–€9.09
2018-Q1	Buy	1.8M	2.5M	+698K	€7.70–€12.90
2017-Q4	Buy	1.4M	1.8M	+400K	€11.96–€16.32
2017-Q3	Buy	1M	1.4M	+396K	€10.79–€16.49
2017-Q2	Buy	386K	1M	+639K	€8.04–€14.45
2017-Q1	Buy	209K	386K	+178K	€8.16–€9.91
2016-Q4	Buy	152K	209K	+57K
2016-Q3	Buy	24K	152K	+128K
2016-Q2	Sell	29K	24K	-4.2K
2016-Q1	Sell	109K	29K	-81K
2015-Q4	Sell	111K	109K	-1.5K
2015-Q3	Sell	381K	111K	-271K

Transactions may be incomplete if the investor has purchased shares of the company before they reached the threshold for reporting set in the Securites Exchange Act or other applicable laws.

← Back to all investors